Delivering Optimal Cancer Care During the Covid-19 Pandemic
Repurposed cancer drug to be tested in COVID-19
COVID-19/SARS-CoV-2 Pandemic
Alzheimer’s: Why the β-amyloid hypothesis is under attack
Role of Immunotherapy on the Survival of Patients with Pancreatic Cancer
Neurodegenerative CNS Disorders: Translation fails again…
Could a Blood Test Screen for Multiple Types of Cancer?
Synairgen has confirmed commencement of first patient dosing in a trial of SNG001 in COVID-19
Bacteria-trapping protein that may provide a new target for tracking and treating breast cancer
Guidance on the Management of Clinical Trials during the COVID-19 (Coronavirus) Pandemic